As Table 3 shows, TMEM147 overexpression was associated with worse OS in patients with HCC (HR: 2.121, p = 0.001), as well as with pathological stage (HR: 1.944, p = 0.017) and tumor status (HR: 1.977, p = 0.004). This evidence concerns the gene TMEM147 and hepatocellular carcinoma.